Answers are grounded in this paper and cite their sources.
To The Editor— We read with great interest the recent systematic review by Marshall et al.1 on creatine and cognition in older adults. Their careful synthesis corroborates many of the methodological concerns raised in this field, including small sample sizes, heterogeneous dosing and outcome protocols, reliance on cross-sectional data, and variable study quality that limit causal inference. Marshall et al.1 reported that most studies suggest positive associations between creatine and cognitive domains, yet they rightly concluded that the overall evidence is sparse and inconsistent. This conclusion resonates with broader critiques of trial design and meta-analytical practices that risk overstating effects.2,3 Furthermore, mechanistic plausibility remains uncertain since it is still unresolved whether supplemented creatine crosses the blood–brain barrier in sufficient quantities to alter cognition in older adults.4,5 We commend Marshall et al.1 for highlighting the need for objective biomarkers of creatine status, standardized dosing, and adequately powered randomized controlled trials. Until such evidence becomes available, creatine supplementation to improve cognition in older adults should be considered promising but unproven, and caution is warranted to avoid premature clinical claims.
No takes yet. Share an insight, caveat, or question.
Marco Machado (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: